Myricx Bio, a cancer therapy spinout based on research carried out at the Crick and @imperialcollegeldn.bsky.social, has reached an agreement to be acquired by @novartis.bsky.social. www.crick.ac.uk/news/2026-07...
Crick and Imperial spinout agrees to be acquired by NovartisMyricx Bio, a cancer therapy spinout based on research carried out at the Francis Crick Institute and Imperial College London, has reached an agreement to be acquired by Novartis.www.crick.ac.uk